{
    "id": 2566,
    "fullName": "CCR2 wild-type",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "Wild-type CCR2 indicates that no mutation has been detected within the CCR2 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 729230,
        "geneSymbol": "CCR2",
        "terms": [
            "CCR2",
            "CC-CKR-2",
            "CCR-2",
            "CCR2A",
            "CCR2B",
            "CD192",
            "CKR2",
            "CKR2A",
            "CKR2B",
            "CMKBR2",
            "MCP-1-R"
        ]
    },
    "variant": "wild-type",
    "createDate": "11/13/2014",
    "updateDate": "08/24/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1461,
            "approvalStatus": "Preclinical",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, the fusion of murine colony stimulating factor 2 with residues 6-76 of Ccl2 (named GMME1) bound to the receptor C-C motif chemokine 2 and induced apoptosis in human and mouse medulloblastoma cell lines (PMID: 21943176).",
            "molecularProfile": {
                "id": 2562,
                "profileName": "CCR2 wild-type"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 50902,
                "name": "medulloblastoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 1327,
                    "pubMedId": 21943176,
                    "title": "A MCP1 fusokine with CCR2-specific tumoricidal activity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21943176"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 1460,
            "approvalStatus": "Preclinical",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, the fusion of murine colony stimulating factor 2 with residues 6-76 of C-C motif chemokine 2 (named GMME1) bound to the receptor Ccr2 and induced apoptosis in a human multiple myeloma cell line and primary human myeloma cells, and also inhibited myeloma tumor growth in mice (PMID: 21943176).",
            "molecularProfile": {
                "id": 2562,
                "profileName": "CCR2 wild-type"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 70004,
                "name": "myeloid neoplasm",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 1327,
                    "pubMedId": 21943176,
                    "title": "A MCP1 fusokine with CCR2-specific tumoricidal activity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21943176"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2562,
            "profileName": "CCR2 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}